<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02715310</url>
  </required_header>
  <id_info>
    <org_study_id>MKG HN 1</org_study_id>
    <nct_id>NCT02715310</nct_id>
  </id_info>
  <brief_title>Haemodynamic Monitoring in Head and Neck Cancer Patients</brief_title>
  <acronym>HMHN</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to estimate the effect of fluid management in regard to postoperative complications&#xD;
      this observatory study will document every kind of fluid intervention peri- and&#xD;
      intraoperatively.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The extend of mass transfusions is known to correlate with postoperative complications.&#xD;
      However, also crystalloid and colloidal infusions are under suspicion to cause postoperative&#xD;
      complications. This study will capture any kind of fluid intervention perioperatively as well&#xD;
      as intraoperatively. Intraoperative fluid management will be documented and matched with the&#xD;
      operation steps respectively. The extend of fluid therapy will be correlated with general&#xD;
      postoperative complications and especially with the survival of microvascular transplants.&#xD;
&#xD;
      For this purpose, there will be four questionaires. After informed consent, the first&#xD;
      questionaire will cover the patient's history, risk factors and previous operations. The&#xD;
      second questionaire will cover intraoperative fluid management, documented with the actual&#xD;
      operation step. Furthermore, it will also intraoperative complications, cardiovascular-active&#xD;
      medication. For closer monitoring, data from Picco will also be included. The third&#xD;
      questionaire will be complete in the ICU covering similar content as the second questionaire.&#xD;
      The last questionaire will cover the patient's progress on the general ward. Fluid management&#xD;
      and tube feeding, as well as general postoperative complication and flap specific&#xD;
      complications will be noted.&#xD;
&#xD;
      This study aims for 50-80 patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>1 week</time_frame>
    <description>General Complications e.g. affecting lung, cardiovascular system, kidneys</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transplant Survival via Clinical Examination</measure>
    <time_frame>One week</time_frame>
    <description>Transplant Survival via Clinical Examination/ Need for further microvascular Transplant</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Postoperative Complications</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood parameters&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Full grown, able to consent patients admitted for major head and neck surgery with planned&#xD;
        microvascular transplants for reconstruction due to tumors in the head and neck region.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years old or older&#xD;
&#xD;
          -  admitted for head and neck surgery with microvascular transplantation due to head and&#xD;
             neck tumors&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  underage&#xD;
&#xD;
          -  missing informed consent&#xD;
&#xD;
          -  revisions and relapse operations&#xD;
&#xD;
          -  non tumor-associated operations&#xD;
&#xD;
          -  surgery without microvascular transplants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denys Loeffelbein, PhD, MD, DDS</last_name>
    <role>Study Chair</role>
    <affiliation>Technical University Muncih</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Mücke, PhD, MD, DDS</last_name>
    <phone>00494140</phone>
    <phone_ext>5866</phone_ext>
    <email>thomas.muecke@tum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Florian Guell, MD</last_name>
    <phone>00494140</phone>
    <phone_ext>4994</phone_ext>
    <email>florian.guell@tum.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Oral and Maxillofacial Surgery, Technische Universität München</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Mücke, PhD, MD, DDS</last_name>
      <phone>00494140</phone>
      <phone_ext>5866</phone_ext>
      <email>thomas.muecke@tum.de</email>
    </contact>
    <contact_backup>
      <last_name>Florian Guell, MD</last_name>
      <phone>00494140</phone>
      <phone_ext>4994</phone_ext>
      <email>florian.guell@tum.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <study_first_submitted>March 7, 2016</study_first_submitted>
  <study_first_submitted_qc>March 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2016</study_first_posted>
  <last_update_submitted>March 22, 2016</last_update_submitted>
  <last_update_submitted_qc>March 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

